Which Trocar Access Site Should We Use in Laparoscopic Appendectomy?

NCT ID: NCT05311995

Last Updated: 2022-04-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-01

Study Completion Date

2022-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Open appendectomy has been used in the treatment of appendicitis, which is among the most common emergency pathologies worldwide, since the end of the 19th century. In the 20th century, laparoscopic appendectomy came to the fore and the frequency of use increased gradually. Despite the frequency of laparoscopic appendectomy, there is no consensus on the best way to perform each procedural step. One of these steps is the trocar entry areas. In this study, investigator's aim is to compare the trocar entry areas, which are various reports in the literature, and to find the localization with the optimal usage area. 140 patients who underwent laparoscopic appendectomy between 2021-2022 were randomized into four groups and included in the study. Demographic data, peroperative findings, complications, length of stay and post-operative VAS values of the patients were evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Four trocar tecnıques groups in literature
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

trocar entry areas:Periumblical, left lower quadrant, suprapubic

Group Type ACTIVE_COMPARATOR

Only different trocar sites

Intervention Type PROCEDURE

Only different trocar sites in literature

Group 2

trocar entry areas: Periumblical, left lower quadrant, right lower quadrant

Group Type ACTIVE_COMPARATOR

Only different trocar sites

Intervention Type PROCEDURE

Only different trocar sites in literature

group 3

trocar entry areas: Periumblical, right lower quadrant, suprapubic

Group Type ACTIVE_COMPARATOR

Only different trocar sites

Intervention Type PROCEDURE

Only different trocar sites in literature

Group 4

trocar entry areas: Periumblical, left lower quadrant, left upper quadrant

Group Type ACTIVE_COMPARATOR

Only different trocar sites

Intervention Type PROCEDURE

Only different trocar sites in literature

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Only different trocar sites

Only different trocar sites in literature

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients who underwent laparoscopic appendectomy

Exclusion Criteria

patients who underwent open surgery and did not want to be involved in the study process
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Inonu University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ersin Gündoğan

Assoc Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ersin Gundogan

Kayseri, Kocasinan, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021/267

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.